"AlphaFold has sparked a wave of innovation by showing people what's possible," said Chris Bahl, the chief scientist at AI Proteins, a Boston startup using AlphaFold to help develop drugs.
"AlphaFold, amazing as it, is just the beginning," Demis Hassabis, the CEO of DeepMind, said on a podcast last year.
AlphaFold2 was built with far more biological and physics knowledge of proteins, Jumper said.
Next uses will be 'progressively harder' as DeepMind stays secretive on its future workJohn Jumper, a senior staff research scientist at DeepMind who helped develop AlphaFold.
"But AI will also continue to progress rapidly, and the folks at DeepMind are very good, so I'm optimistic."